Biodesix Q3 Revenue USD 24.041 Million Vs. IBES Estimate USD 27.5 Million
Nov 05 (Reuters) - Biodesix Q3 operating expenses USD 30.153 million.
- Q3 net income USD -8.032 million
Nov 05 (Reuters) - Biodesix Q3 operating expenses USD 30.153 million.
Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.